Le D T, Donnelly K J, Wu N, Sevilla B K, Rapaport S I
Department of Pathology, University of California, San Diego, USA.
Thromb Haemost. 1997 Mar;77(3):481-5.
The original tissue factor-dependent factor V assay for activated protein C resistant factor Va (Blood 1995; 85: 1704-1711) has been modified to use a calcium containing thromboplastin and to express results as an observed to expected ratio (Obs/Exp.). The latter permits establishing a normal range independent of variations due to differences in reagents. Comparing Obs/Exp ratios with DNA analysis in 72 persons revealed that an Obs/Exp ratio of 0.6 distinguished without overlap normals from heterozygotes for FV R506Q. Three homozygotes had a ratio of < 0.1. Application of this Obs/Exp cut-off ratio of 0.6 to a total of 226 plasma samples tested to date discriminated without overlap between normals and heterozygotes. We conclude that this assay-readily adaptable to any dedicated coagulation laboratory and capable of yielding reliable results in all clinical circumstances in which testing is indicated-can distinguish between normals and heterozygotes for the FV R506Q mutation without the need for confirmatory DNA analysis.
最初用于检测活化蛋白C抵抗因子Va的组织因子依赖性因子V检测方法(《血液》1995年;85卷:1704 - 1711页)已进行改良,采用含钙凝血活酶,并将结果表示为观察值与预期值之比(Obs/Exp.)。后者使得能够建立一个不受试剂差异导致的变化影响的正常范围。对72人的Obs/Exp比值与DNA分析进行比较发现,Obs/Exp比值为0.6能够无重叠地区分FV R506Q杂合子与正常人。三名纯合子的比值<0.1。将该Obs/Exp截止比值0.6应用于迄今为止检测的总共226份血浆样本,能够无重叠地区分正常人和杂合子。我们得出结论,这种检测方法——易于适用于任何专门的凝血实验室,并且在所有需要检测的临床情况下都能产生可靠结果——无需进行验证性DNA分析就能区分FV R506Q突变的正常人和杂合子。